Pages that link to "Q42282978"

The following pages link to Inhibition of the growth of influenza viruses in vitro by 4-guanidino-2,4-dideoxy-N-acetylneuraminic acid (Q42282978):

Displaying 23 items.

• Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase (Q27760264) (← links)
• The anti-influenza virus agent 4-GU-DANA (zanamivir) inhibits cell fusion mediated by human parainfluenza virus and influenza virus HA. (Q28344907) (← links)
• Synthesis and anti-influenza virus activity of novel pyrimidine derivatives (Q28368200) (← links)
• Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071. (Q28369317) (← links)
• Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection (Q28379409) (← links)
• Generation and characterization of a mutant of influenza A virus selected with the neuraminidase inhibitor BCX-140. (Q28379467) (← links)
• Safety and efficacy of intravenous zanamivir in preventing experimental human influenza A virus infection. (Q30304110) (← links)
• Zanamivir: a rational approach to influenza B. (Q30327955) (← links)
• New approaches to influenza chemotherapy. Neuraminidase inhibitors (Q30472797) (← links)
• Approaches and strategies for the treatment of influenza virus infections (Q33730165) (← links)
• Zanamivir: a review of its use in influenza (Q33768776) (← links)
• Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studies (Q33978456) (← links)
• Efficacy of zanamivir against avian influenza A viruses that possess genes encoding H5N1 internal proteins and are pathogenic in mammals (Q33981934) (← links)
• Zanamivir: an update of its use in influenza (Q34492611) (← links)
• Characterization of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2en (Q35857200) (← links)
• Development of antivirals against influenza (Q36181153) (← links)
• The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses (Q40837861) (← links)
• Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor (Q41042625) (← links)
• Glycosylation of haemagglutinin and stalk-length of neuraminidase combine to regulate the growth of avian influenza viruses in tissue culture (Q43733762) (← links)
• Application of computational methods for anticancer drug discovery, design, and optimization (Q50111842) (← links)
• Zanamivir. (Q54138583) (← links)
• Summary of the III International Consensus Symposium on Combined Antiviral Therapy (Q77103107) (← links)
• Influenza virus resistance to neuraminidase inhibitors (Q79340361) (← links)